Try our Advanced Search for more refined results

Impax Opens New Front In Adderall Battle With Shire

By Marius Meland (November 11, 2005, 12:00 AM EST) -- Impax Laboratories Inc. is taking action against the newest patent issued for anti-depressant Adderall XR, countersuing Shire Laboratories Inc. in federal court. At the same time, Shire is lobbying the FDA to further restrict the generic manufacture of the drug....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!